Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Conner Kummerlowe
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 20 December 2021 Accepted: 12 August 2022 Permissions Request permissions for this article.
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 12 January 2022 Accepted: 10 August 2022 Permissions Request permissions for this article.
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 14 February 2022 Accepted: 20 July 2022 Permissions Request permissions for this article. Acknowledgments We thank C.
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 29 April 2021 Accepted: 19 July 2022 Permissions Request permissions for this article.
A targetable pathway in neutrophils mitigates both arterial and venous thrombosis
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 29 May 2021 Accepted: 28 July 2022 Permissions Request permissions for this article. Acknowledgments We thank T.
Single-cell profiling of environmental enteropathy reveals signatures of epithelial remodeling and immune activation
Information Published In Science Translational Medicine Volume 14 | Issue 660 August 2022 Copyright Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 5 April 2021 Accepted: 12 July 2022 Permissions Request permissions for this article.
A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells
Information Published In Science Translational Medicine Volume 13 | Issue 592 May 2021 Copyright Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submission history Received: 11 May 2020 Accepted: 26 February 2021 Permissions Request permissions for this article. Acknowledgments We thank D.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Conner
Contact Conner, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack